Aemetis Stock Alpha and Beta Analysis

AMTX Stock  USD 2.84  0.11  4.03%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aemetis. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aemetis over a specified time horizon. Remember, high Aemetis' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aemetis' market risk premium analysis include:
Beta
1.86
Alpha
0.21
Risk
6.07
Sharpe Ratio
0.0136
Expected Return
0.0825
Please note that although Aemetis alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Aemetis did 0.21  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Aemetis stock's relative risk over its benchmark. Aemetis has a beta of 1.86  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aemetis will likely underperform. Enterprise Value is likely to rise to about 359.9 M in 2025, despite the fact that Book Value Per Share is likely to grow to (6.23).

Enterprise Value

359.94 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Aemetis Backtesting, Aemetis Valuation, Aemetis Correlation, Aemetis Hype Analysis, Aemetis Volatility, Aemetis History and analyze Aemetis Performance.
For more information on how to buy Aemetis Stock please use our How to Invest in Aemetis guide.

Aemetis Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aemetis market risk premium is the additional return an investor will receive from holding Aemetis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aemetis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aemetis' performance over market.
α0.21   β1.86

Aemetis expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aemetis' Buy-and-hold return. Our buy-and-hold chart shows how Aemetis performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Aemetis Market Price Analysis

Market price analysis indicators help investors to evaluate how Aemetis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aemetis shares will generate the highest return on investment. By understating and applying Aemetis stock market price indicators, traders can identify Aemetis position entry and exit signals to maximize returns.

Aemetis Return and Market Media

The median price of Aemetis for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 is 2.99 with a coefficient of variation of 16.26. The daily time series for the period is distributed with a sample standard deviation of 0.51, arithmetic mean of 3.16, and mean deviation of 0.43. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Aemetis Announces Support for Updated Low Carbon Fuel Standard and Encourages CARB Adoption on November 8th
11/05/2024
2
Aemetis Reports Revenues of 81 Million for the Third Quarter 2024
11/12/2024
3
Aemetis, Inc. Q3 2024 Earnings Call Transcript
11/13/2024
4
Acquisition by Barton Francis P of 5000 shares of Aemetis subject to Rule 16b-3
11/18/2024
5
Acquisition by Simon Timothy Alan of 5191 shares of Aemetis subject to Rule 16b-3
11/21/2024
6
Aemetis India Completes 103 Million of Biodiesel Deliveries to OMCs in 2024 and Receives ...
12/03/2024
7
Aemetis Biogas Starts Production From Tenth Dairy Digester With Additional Digesters in Final Stages of Commissioning and Construction
12/10/2024
8
Disposition of 9445 shares by Barton Francis P of Aemetis at 21.1321 subject to Rule 16b-3
12/13/2024
9
Aemetis Registrations Approved by the IRS for 45Z Production Tax Credits
12/17/2024

About Aemetis Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aemetis or other stocks. Alpha measures the amount that position in Aemetis has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Payables Turnover10.015.755.178.84
Days Of Inventory On Hand6.4936.1541.5726.63

Aemetis Upcoming Company Events

As portrayed in its financial statements, the presentation of Aemetis' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aemetis' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aemetis' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aemetis. Please utilize our Beneish M Score to check the likelihood of Aemetis' management manipulating its earnings.
14th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Aemetis

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Aemetis Stock Analysis

When running Aemetis' price analysis, check to measure Aemetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aemetis is operating at the current time. Most of Aemetis' value examination focuses on studying past and present price action to predict the probability of Aemetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aemetis' price. Additionally, you may evaluate how the addition of Aemetis to your portfolios can decrease your overall portfolio volatility.